Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Infantile Epileptic Spasms Syndrome: early-phase trial registry

1 of 1 indexed Infantile Epileptic Spasms Syndrome trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Infantile Epileptic Spasms Syndrome: 1 US clinical trial tracked, 1 recruiting.

Infantile Epileptic Spasms Syndrome is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Los Angeles, running 1 of these trials.

Enrollment posture brief

Registry condition infantile-epileptic-spasms-syndrome

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Infantile Epileptic Spas (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Infantile Epileptic Spasms Syndrome

Infantile Epileptic Spasms Syndrome lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Infantile Epileptic Spasms Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Infantile Epileptic Spasms Syndrome is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Infantile Epileptic Spasms Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Famotidine Drug
1 trials
Prednisolone Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Infantile Epileptic Spasms Syndrome trials. A trial with sites in several states counts in each.

California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Infantile Epileptic Spasms Syndrome page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infantile Epileptic Spasms Syndrome condition card totals 1 registered trials; most-linked intervention Famotidine; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.